DK175016B1 - Bromcryptinpræparater - Google Patents

Bromcryptinpræparater Download PDF

Info

Publication number
DK175016B1
DK175016B1 DK198500867A DK86785A DK175016B1 DK 175016 B1 DK175016 B1 DK 175016B1 DK 198500867 A DK198500867 A DK 198500867A DK 86785 A DK86785 A DK 86785A DK 175016 B1 DK175016 B1 DK 175016B1
Authority
DK
Denmark
Prior art keywords
bromocriptine
release
composition according
hours
capsule
Prior art date
Application number
DK198500867A
Other languages
Danish (da)
English (en)
Other versions
DK86785D0 (da
DK86785A (da
Inventor
Othmar Zueger
Norman Mazer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK86785D0 publication Critical patent/DK86785D0/da
Publication of DK86785A publication Critical patent/DK86785A/da
Application granted granted Critical
Publication of DK175016B1 publication Critical patent/DK175016B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198500867A 1984-02-29 1985-02-26 Bromcryptinpræparater DK175016B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8405227 1984-02-29
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (3)

Publication Number Publication Date
DK86785D0 DK86785D0 (da) 1985-02-26
DK86785A DK86785A (da) 1985-08-30
DK175016B1 true DK175016B1 (da) 2004-04-26

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198500867A DK175016B1 (da) 1984-02-29 1985-02-26 Bromcryptinpræparater

Country Status (26)

Country Link
JP (1) JPS60202812A (xx)
AT (1) AT387716B (xx)
AU (2) AU586621B2 (xx)
BE (1) BE901810A (xx)
CA (1) CA1256374A (xx)
CH (2) CH666406A5 (xx)
DE (1) DE3505743C2 (xx)
DK (1) DK175016B1 (xx)
ES (1) ES8705223A1 (xx)
FR (1) FR2560047B1 (xx)
GB (1) GB8405227D0 (xx)
GR (1) GR850506B (xx)
HK (1) HK85490A (xx)
HU (1) HU196121B (xx)
IE (1) IE58235B1 (xx)
IL (1) IL74459A (xx)
IT (1) IT1199948B (xx)
LU (1) LU85791A1 (xx)
MX (1) MX9203626A (xx)
NL (1) NL194231C (xx)
NZ (1) NZ211247A (xx)
PH (1) PH23266A (xx)
PT (1) PT80015B (xx)
SE (2) SE462259B (xx)
SG (1) SG69390G (xx)
ZA (1) ZA851546B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (xx) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
LU85791A1 (fr) 1985-12-11
CH667009A5 (de) 1988-09-15
HUT38254A (en) 1986-05-28
CH666406A5 (de) 1988-07-29
FR2560047A1 (fr) 1985-08-30
IT8547703A0 (it) 1985-02-20
JPS60202812A (ja) 1985-10-14
IL74459A0 (en) 1985-05-31
AU618599B2 (en) 1992-01-02
HU196121B (en) 1988-10-28
CA1256374A (en) 1989-06-27
AT387716B (de) 1989-03-10
DK86785D0 (da) 1985-02-26
PT80015B (pt) 1987-09-18
FR2560047B1 (fr) 1988-01-15
IL74459A (en) 1988-12-30
NL8500417A (nl) 1985-09-16
ZA851546B (en) 1986-10-29
AU3913685A (en) 1985-09-05
BE901810A (fr) 1985-08-26
DE3505743A1 (de) 1985-08-29
NZ211247A (en) 1989-02-24
ES540807A0 (es) 1987-05-01
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
IE850495L (en) 1985-08-29
IE58235B1 (en) 1993-08-11
JPH0448776B2 (xx) 1992-08-07
ATA58085A (de) 1988-08-15
MX9203626A (es) 1992-09-01
AU3500689A (en) 1989-09-14
ES8705223A1 (es) 1987-05-01
SE8500961D0 (sv) 1985-02-27
PH23266A (en) 1989-06-23
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
DK86785A (da) 1985-08-30
HK85490A (en) 1990-10-25
IT1199948B (it) 1989-01-05
SG69390G (en) 1990-10-26
SE462259B (sv) 1990-05-28
GB8405227D0 (en) 1984-04-04
SE8500961L (sv) 1985-08-30
DE3505743C2 (de) 1995-02-16
GR850506B (xx) 1985-06-28
NL194231B (nl) 2001-06-01

Similar Documents

Publication Publication Date Title
US4556678A (en) Sustained release propranolol tablet
EP0893998B1 (en) Colonic delivery of nicotine to treat inflammatory bowel disease
US5624677A (en) Controlled release of drugs delivered by sublingual or buccal administration
DK176018B1 (da) Formulering med pyridoxin, HC1 og doxylaminsuccinat, dets anvendelse og fremgangsmåde til dets fremstilling
CA2289260C (en) Controlled release of drugs delivered by sublingual or buccal administration
KR101207618B1 (ko) 심혈관계 질환 치료용 약제학적 제제
US20030175341A1 (en) Controlled release formulation
US20110177168A1 (en) Composition
JP2000511170A (ja) 医薬組成物
AU2004275469A1 (en) HRT formulations
EP0749308B1 (en) Film coated tablet of paracetamol and domperidone
KR101272470B1 (ko) 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물
US5407687A (en) Ranitidine solid dosage form
GB2154874A (en) Bromocriptine compositions
EP3013327A1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
PL194702B1 (pl) Powlekana kompozycja farmaceutyczna w stałej postaci dawkowania i lek zawierający tę kompozycję
DK167138B1 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK175016B1 (da) Bromcryptinpræparater
KR101697773B1 (ko) 독소필린을 포함하는 변형 방출 조성물
EP1423097A1 (en) Controlled release formulation of clarithromycin or tinidazol
WO2011126327A2 (en) Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
CN117205164B (zh) 一种盐酸沙丙蝶呤片剂及其制备方法
EP0975337A2 (en) Fast release compressed tablet of flurbiprofen
JPH0466846B2 (xx)
WO2024165966A1 (en) Gastroretentive extended release compositions of riociguat

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2004 00033

Filing date: 20041026

Extension date: 20090124

PUP Patent expired
CTFW Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawn

Spc suppl protection certif: CA 2004 00033